Company intelligence / Profile preview

Ulthera

Mesa, Arizona, United Statesultherapy.com ↗

Ownership: Private
Employees: ~150
Development stage: Commercial

Overview

Ulthera developed the FDA-cleared Ultherapy system, a non-invasive microfocused ultrasound device for lifting skin on the neck, brow, under chin, and improving lines/wrinkles on the décolletage. The company built a strong clinical evidence base with over 37 clinical trials involving more than 1,200 patients since 2005. The system is widely adopted globally as a gold standard in non-surgical skin lifting procedures

Therapeutic areas: Dermatology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Ulthera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ulthera.

Explore the full profile